Non-alcoholic steatohepatitis-associated hepatic fibrosis and hepatocellular carcinoma in a combined mouse model of genetic modification and dietary challenge.

Amano, Yuichiro; Shimizu, Fumi; Yasuno, Hironobu; Harada, Ayako; Tsuchiya, Shuntarou; Isono, Osamu; Nagabukuro, Hiroshi; Tozawa, Ryuichi

Amano, Yuichiro; Shimizu, Fumi; Yasuno, Hironobu; Harada, Ayako; Tsuchiya, Shuntarou; Isono, Osamu; Nagabukuro, Hiroshi; Tozawa, Ryuichi.

Afiliação

Amano Y; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Shimizu F; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Yasuno H; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Harada A; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Tsuchiya S; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Isono O; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Nagabukuro H; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Tozawa R; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.

Hepatol Res ; 47(1): 103-115, 2017 Jan.

Article em En | MEDLINE | ID: mdl-26992446

Palavras-chave

CDAA diet; LDL receptor knockout mouse; adenoma; carcinoma; hepatic fibrosis; non-alcoholic steatohepatitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google